QA: Cambrex CORP in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000820081_2017_Cambrex_CORP.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000820081, Cambrex CORP

  xvar xval
0 AssetsCurrent 322,655,000
1 IntangibleAssetsNetIncludingGoodwill 55,123,000
2 PropertyPlantAndEquipmentNet 217,092,000
3 remainder_Assets 16,995,000
4 LiabilitiesCurrent 95,462,000
5 LiabilitiesNoncurrent 21,946,000
6 remainder_Liabilities 89,030,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 60,889,857
9 ResearchAndDevelopmentExpense 14,155,620
10 remainder_Expenses 326,688,827
11 remainder_Revenues 501,432,572
12 remainder_NetIncome -4,398,852
13 remainder_ComprehensiveNetIncome -10,088,228
  yvar yval
0 Assets 611,865,000
1 Liabilities 206,438,000
2 Expenses 401,734,304
3 Revenues 501,432,572
4 StockholdersEquity 405,427,000
5 NetIncome 95,299,416
6 ComprehensiveNetIncome 90,255,302
7 BaseVar 867,978,478
8 EconomicCapitalRatiobeforeLimitedLiability 2.38
9 EconomicCapitalRatio 3.28

Edgar->Model Mapping

Feature Distribution

Change over Time